CANSINOBIO (06185) reported a net profit attributable to shareholders of RMB16.2913 million for the first three quarters, up 12.82% year on year.
CANSINOBIO (06185) announced its results for the first three quarters of 2026. For the nine months ended September 30, 2026, it achieved operating revenue of RMB882 million, up 27.4% year on year; net profit attributable to shareholders of the listed company was RMB16.2913 million, up 12.82% year on year. Basic earnings per share were RMB0.07.
CANSINOBIO (06185) announced its results for the first three quarters of 2026. For the nine months ended September 30, 2026, it achieved operating revenue of RMB882 million, up 27.4% year on year; net profit attributable to shareholders of the listed company was RMB16.2913 million, up 12.82% year on year. Basic earnings per share were RMB0.07.
Related Articles
BRII-B (02137) repurchased 131,500 shares for HK$124,000 on October 27.
Befar Group (06745): Sun Huiqing Appointed as Executive Director
YONGDA AUTO (03669) repurchased 500,000 shares on October 27 for HK$348,600.
BRII-B (02137) repurchased 131,500 shares for HK$124,000 on October 27.
Befar Group (06745): Sun Huiqing Appointed as Executive Director
YONGDA AUTO (03669) repurchased 500,000 shares on October 27 for HK$348,600.
